Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma of Skin Stage IV”

840 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 840 results

Early research (Phase 1)Study completedNCT03229278
What this trial is testing

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more
Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Study completedNCT00026143
What this trial is testing

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Looking for participantsNCT07130032
What this trial is testing

Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade

Who this might be right for
Metastatic Non-small Cell Lung Cancer (NSCLC)Metastatic Cutaneous Melanoma
EuroCityClinic LLC 90
Early research (Phase 1)Study completedNCT00005633
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Early research (Phase 1)Study completedNCT00005943
What this trial is testing

Gene Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Colorado, Denver
Early research (Phase 1)Study completedNCT00313508
What this trial is testing

Dendritic Cell Vaccination During Lymphoid Reconstruction

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 18
Testing effectiveness (Phase 2)Looking for participantsNCT05970497
What this trial is testing

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerMelanoma Stage IIIMelanoma Stage IV+1 more
Krystal Biotech, Inc. 240
Testing effectiveness (Phase 2)Ended earlyNCT03050060
What this trial is testing

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Who this might be right for
Metastatic Kidney CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
University of Washington 21
Testing effectiveness (Phase 2)Study completedNCT01740297
What this trial is testing

Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma

Who this might be right for
Melanoma
Amgen 217
Testing effectiveness (Phase 2)Study completedNCT01397708
What this trial is testing

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

Who this might be right for
Melanoma
Alaunos Therapeutics 26
Early research (Phase 1)Study completedNCT03002376
What this trial is testing

An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 47
Testing effectiveness (Phase 2)UnknownNCT00004025
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Genzyme, a Sanofi Company 36
Testing effectiveness (Phase 2)Ended earlyNCT03391050
What this trial is testing

APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma

Who this might be right for
Melanoma
Aprea Therapeutics 3
Testing effectiveness (Phase 2)Study completedNCT00289627
What this trial is testing

A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 155
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00109863
What this trial is testing

Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
University of Wisconsin, Madison 14
Early research (Phase 1)Study completedNCT00004016
What this trial is testing

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
University of Rochester
Testing effectiveness (Phase 2)Study completedNCT00021164
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00602199
What this trial is testing

ABT-510 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 42
Next Page